Neurocrine Biosciences Director Files to Sell 14,700 Shares
Director George Morrow of Neurocrine Biosciences plans to sell 14,700 shares of common stock, valued at approximately $2.15 million.
Cantor Fitzgerald Income Trust Sets Virtual Annual Meeting
Cantor Fitzgerald Income Trust, Inc. announces its virtual annual stockholders meeting for December 9, 2026, focusing on key proposals and shareholder engagement.
Birchwood Financial Partners reveals $134.2M in holdings
Birchwood Financial Partners, Inc. discloses its investment holdings valued at $134.2 million in a recent SEC filing, highlighting key positions in various sectors.
Glaxis Capital Management reveals $42M portfolio in 13F-HR
Glaxis Capital Management's latest 13F-HR filing shows a portfolio valued at $42 million, highlighting strategic investments across various sectors.
JPMorgan Chase Financial Co. unveils new structured notes
JPMorgan Chase Financial Co. LLC has filed a preliminary pricing supplement for new structured investment notes linked to major stock indices.
Kenneth J. West plans to sell shares of Honeywell International
Kenneth J. West has filed to sell 879 shares of Honeywell International Inc. following the vesting of restricted stock units.
LiveRamp Holdings merges with MMS USA Holdings, Inc.
LiveRamp Holdings, Inc. completes merger with MMS USA Holdings, reshaping the data processing industry landscape.
BofA Finance LLC announces $2.36 million in new notes
BofA Finance LLC has filed a pricing supplement for $2.36 million in Buffered Auto-Callable Return Notes, fully guaranteed by Bank of America Corporation.
HSBC USA Inc. Offers Callable Contingent Income Notes
HSBC USA Inc. files a pricing supplement for callable contingent income barrier notes, enhancing its financial offerings in the competitive banking sector.
Robinhood officer sells 4,473 shares of common stock
Robinhood's Dara Bazzano sells 4,473 shares of common stock, reflecting ongoing activity within the competitive security brokerage industry.
JPMorgan Chase Financial Co. announces new Medium-Term Notes
JPMorgan Chase Financial Co. LLC is launching Medium-Term Notes linked to Asian indexes, signaling a shift in offerings within the national commercial banking sector.
Citigroup files for new 5-year autocallable securities offering
Citigroup Inc. has filed a preliminary pricing supplement for a new offering of 5-year autocallable contingent coupon securities, diversifying its financial products.
JPMorgan Chase Financial Co. unveils new structured notes
JPMorgan Chase Financial Co. has filed a preliminary pricing supplement for Auto Callable Contingent Interest Notes, indicating a strategic move in structured investments.
Citigroup files preliminary prospectus for new securities
Citigroup Global Markets Holdings Inc. has filed a preliminary prospectus for a new financial product linked to the S&P 500 index, indicating innovation in the sector.
Citigroup files preliminary pricing supplement for new securities
Citigroup Inc. files a preliminary pricing supplement for new securities linked to the S&P 500 index, signaling strategic growth in the commercial banking sector.
Xeris Biopharma officer sells 75,000 shares in Form 144
Xeris Biopharma's Beth Hecht sells 75,000 shares, signaling ongoing executive transactions in the pharmaceutical preparations sector.
LiveRamp Holdings deregisters securities after merger
LiveRamp Holdings has deregistered its unsold securities following its merger with MMS USA Holdings, marking a significant shift in the data processing industry.
LTDR Holdco LLC raises $5.9 million in private offering
LTDR Holdco LLC has completed a private offering, raising $5.9 million from 23 accredited investors, marking a significant milestone for the company.
Bank of Montreal Issues $124,000 in Senior Medium-Term Notes
Bank of Montreal announces issuance of $124,000 in Senior Medium-Term Notes linked to the S&P 500 Futures Excess Return Index, maturing in 2031.
Citigroup Global Markets Files for New Securities Linked to S&P 500
Citigroup Global Markets Holdings Inc. files a preliminary pricing supplement for new securities linked to the S&P 500 Futures, showcasing innovation in financial products.